New treatment modalities in superficial bladder cancer
نویسندگان
چکیده
منابع مشابه
Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment
This review deals with the role of microorganisms in spontaneous regression of a tumour. Spontaneous cancer regression is a phenomenon that has been described for many centuries. One of the most well known methods of inducing spontaneous regression of cancer is the application of Coley's toxin (heat-killed Streptococcus pyogenes and Serratia marcescens), which has been used for the successful t...
متن کاملGuidelines on bladder cancer.
OBJECTIVES On behalf of the European Association of Urology (EAU) guidelines for diagnosis, therapy and follow-up of bladder cancer patients were established. Criteria for recommendations were evidence based, and included aspects of cost-effectiveness and clinical feasibility. METHOD A systematic literature research using Medline Services was conducted. References were weighted by a panel of ...
متن کاملIncorporating covariates in a flowgraph model for bladder carcinoma
Superficial bladder cancer is a significant public health problem with remaining challenges. Urologists need tools to accurately predict the real evolution of the disease, that help them to improve treatment modalities and follow-up schemes. Multi-state stochastic processes are a convenient framework for modeling the process, and the statistical flowgraph approach is an efficient tool to perfor...
متن کاملThe current diagnosis of superficial bladder cancer must be reconsidered.
The high recurrence and progression rates in superficial bladder cancer are partially related to the deficiencies of the standard conventional diagnostic modalities. Therefore, innovative noninvasive and invasive detection devices have been studied during the last decade. New diagnostic urine markers are under intensive investigation in order to exclude the presence of urothelial cancer, but th...
متن کاملEvolving immunotherapeutic strategies in bladder and renal cancer.
For patients with urological cancers, immunotherapy is currently a treatment option for metastatic renal cell carcinoma, and those with "high risk" superficial bladder cancers. In this review, our current understanding of tumour immune escape is discussed. The principles and role of current immunotherapies for these tumours are described, and new areas of immunotherapeutic promise are highlighted.
متن کامل